Results 171 to 180 of about 53,142 (237)

Pharmacokinetic Comparison Between a Fixed-Dose Combination of Atorvastatin/Fenofibrate 20/145 mg and the Corresponding Individual Components. [PDF]

Clin Pharmacol Drug Dev
Lee S, Khwarg J, Bae S, Park DM, Park H, Lee S, Yu KS.   +6 more
europepmc   +1 more source

Emerging Role of Statin Therapy in Preventing Anthracycline-Induced Cardiotoxicity. [PDF]

Cardiol Res Pract
Mansour E, Raji NA, Salloum P, Jreij N, Ayoub TM, Merheb M, Attieh P, Harbieh B, Harb F, Azar S, Ghadieh HE.   +10 more
europepmc   +1 more source

Comparative pharmacokinetics of a candesartan/amlodipine/atorvastatin fixed-dose combination 8 mg/5 mg/10 mg versus separate tablets in healthy subjects: a partial replicated crossover study. [PDF]

Transl Clin Pharmacol
Kim SY, Kwak YG, Kim MG, Moon SJ.
europepmc   +1 more source

Coenzyme Q10 protects against atorvastatin-induced hepatotoxicity via attenuation of oxidative stress and functional modulation of CYP3A1. [PDF]

BMC Pharmacol Toxicol
Abdel-Rasol MA, Anwar MS, Taha HA, El-Sayed WM, AbdelRaouf K.   +4 more
europepmc   +1 more source

Differential effects of fresh and black garlic extracts on oxidative stress regulation and anti-inflammatory response properties in human HepG2 cells: An <i>in vitro</i> study. [PDF]

Front Pharmacol
Almughamisi M, Amer F, Alqahtani NK, Felemban AH, Jawharji MT, Hafiz HA, Wazzan H, Altuwairki D, Alharbi HF, Algheshairy RM, Altalhi R, Qahl SH, Alzahrani MS, Abu Ali OA, Sami R, Izmirly AM.   +15 more
europepmc   +1 more source

Atorvastatin reduces recurrent decompensation events in advanced cirrhosis in a randomized placebo-controlled trial. [PDF]

Sci Rep
Glal KAM, El-Haggar SM, Abdel-Salam SM, Mostafa TM.   +3 more
europepmc   +1 more source

Mechanistic insights into atorvastatin-induced hepatotoxicity: molecular pathways, clinical relevance, and strategies for safer personalized therapy. [PDF]

Clin Exp Med
Abdel-Rasol MA, El-Sayed WM.
europepmc   +1 more source

Corrigendum to Synergistic effects of arsenic trioxide and atorvastatin on proliferation and apoptosis in acute lymphoblastic leukemia cells [Leukemia Research Reports 25 (2026) 100570.1-1]. [PDF]

Leuk Res Rep
Khodaei SH, Sabetkam S, Mazloumi Z, Rafat A, Hekari D, Asl KD.   +5 more
europepmc   +1 more source

Metabolic, enterohepatic and gut microbial effects of atorvastatin in healthy men. [PDF]

Endocr Connect
Thomasen M, Misiakou MA, Li SS, Rodriguez de Evgrafov MC, Lynggaard MB, Kårhus ML, Brønden A, Kornholt J, Chávez-Talavera O, Tailleux A, Staels B, Descat A, Hartmann B, Wewer Albrechtsen NJ, Rehfeld JF, Holst JJ, Vilsbøll T, Ellegaard AM, Sommer MOA, Sonne DP, Knop FK.   +20 more
europepmc   +1 more source

Atorvastatin-Associated Liver Injury: Outcome After Statin Rechallenge. [PDF]

Fundam Clin Pharmacol
Bertin B, Lacotte V, Cracowski JL, Gaiffe A, Dumortier J, Vial T.   +5 more
europepmc   +1 more source